SNN
Smith & Nephew PLCPrice & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SNN
this stock
Smith & Nephew PLC
|
$12.84B | -7.3% | — | — | 0.8% |
|
ABT
Abbott Laboratories
|
$164.43B | -23.6% | +5.7% | 26.4 | 1.3% |
|
SYK
Stryker Corp
|
$125.40B | -6.8% | +11.2% | 37.9 | 1.6% |
|
MDT
Medtronic plc
|
$105.46B | -13.9% | +8.4% | 22.1 | 1.4% |
|
BSX
Boston Scientific Corp
|
$66.87B | -53.0% | +5.5% | 18.8 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SNN | +4.0% | -1.3% | -4.7% | +4.0% | -7.3% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +4.1% | -2.1% | -12.1% | +4.1% | -16.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.